key: cord-0754696-7gaelfy4
authors: Ciccosanti, Fabiola; Di Rienzo, Martina; Romagnoli, Alessandra; Colavita, Francesca; Refolo, Giulia; Castilletti, Concetta; Agrati, Chiara; Brai, Annalaura; Manetti, Fabrizio; Botta, Lorenzo; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Piacentini, Mauro; Fimia, Gian Maria
title: Proteomic Analysis Identifies the RNA Helicase DDX3X as a Host Target Against SARS-CoV-2 Infection
date: 2021-03-26
journal: Antiviral Res
DOI: 10.1016/j.antiviral.2021.105064
sha: ddf44016d9f68b2c84214cdc7ddfc3040ea693bc
doc_id: 754696
cord_uid: 7gaelfy4

COVID-19 is currently a highly pressing health threat and therapeutic strategies to mitigate the infection impact are urgently needed. Characterization of the SARS-CoV-2 interactome in infected cells may represent a powerful tool to identify cellular proteins hijacked by viruses for their life cycle and develop host-oriented antiviral therapeutics. Here we report the proteomic characterization of host proteins interacting with SARS-CoV-2 Nucleoprotein in infected Vero E6 cells. We identified 24 high-confidence proteins mainly playing a role in RNA metabolism and translation, including RNA helicases and scaffold proteins involved in the formation of stress granules, cytoplasmic aggregates of messenger ribonucleoproteins that accumulate as a result of stress-induced translation arrest. Analysis of stress granules upon SARS-CoV-2 infection showed that these structures are not induced in infected cells, neither eIF2α phosphorylation, an upstream event leading to stress-induced translation inhibition. Notably, we found that G3BP1, a stress granule component that associates with the Nucleoprotein, is required for efficient SARS-CoV-2 replication. Moreover, we showed that the Nucleoprotein-interacting RNA helicase DDX3X colocalizes with viral RNA foci and its inhibition by small molecules or small interfering RNAs significantly reduces viral replication. Altogether, these results indicate that SARS-CoV-2 subverts the stress granule machinery and exploits G3BP1 and DDX3X for its replication cycle, offering groundwork for future development of host-directed therapies.

A b s tra c t C O V ID -19 is c urre ntly a hig hly pres s ing he a lth thre a t a nd the ra peutic s tra te g ie s to m itig a te the infe c tion im pa c t a re urg e ntly nee de d. C ha ra c teriz a tion of the S A R S -C oV -2 inte ra c tom e in infec te d c e lls m a y re pres e nt a powe rful tool to ide ntify c e llula r prote ins hija c ke d by virus e s for the ir life c yc le a nd dev e lop hos t-orie nte d a ntivira l thera pe utic s .

H ere we re port the prote om ic c ha ra c te riz a tion of hos t prote ins intera c ting with S A R S -C oV -2 N uc le oprotein in infe c ted V ero E 6 c ells . W e ide ntified 24 hig h-c onfide nc e proteins m a inly pla ying a role in R N A m e ta bolis m a nd tra ns la tion, inc luding R N A helic a s es a nd s c a ffold proteins involve d in the form a tion of s tres s g ra nule s , c ytopla s m ic a g g re g a te s of m es s e ng e r ribonuc le oproteins tha t a c c um ula te a s a res ult of s tre s s -induc e d tra ns la tion a rres t. A na lys is of s tres s g ra nule s upon S A R S -C oV -2 infec tion s howed tha t the s e s truc ture s a re not induc e d in infec te d c ells , ne ither e IF 2  phos phoryla tion, a n ups tre a m e ve nt lea ding to s tre s s -induc e d tra ns la tion inhibition. N ota bly, we found tha t G 3B P 1, a s tre s s g ra nule c om pone nt tha t a s s oc ia tes with the N uc leoprote in, is re quire d for effic ie nt S A R S -C oV -2 re plic a tion. More over, we s howe d tha t the N uc leoprote in-inte ra c ting R N A helic a s e D D X 3X c oloc a liz e s with vira l R N A foc i a nd its inhibition by s m a ll m ole c ule s or s m a ll interfe ring R N A s s ig nific a ntly re duc e s vira l replic a tion.

A ltog e ther, the s e res ults indic a te tha t S A R S -C oV -2 s ubv erts the s tre s s g ra nule m a c hine ry a nd ex ploits G 3B P 1 a nd D D X 3 X for its replic a tion c yc le, offering g roundwork for future de ve lopm e nt of hos t-direc te d the ra pie s . Insulin-like growth factor 2 mR NA-binding protein; LDH: Lactate dehydrogenase; ME M: Modified E agle Medium; NS Ps: non-structural proteins; PABPC 3: Polyadenylate-binding protein 3; PP1: Protein phosphatase 1; qR T-

As every obligate intracellular parasite, SARS-CoV-2, the causative agent of COVID-19, needs to hijack a large series of host factors to facilitate its replication (de Wilde et al., 2018; Fung and Liu, 2019) . Moreover, SARS-CoV-2 has to establish interactions with a complex network of host antiviral pathways in order to inhibit or subvert them (Sa Ribero et al., 2020; Lei et al., 2020) . In-depth understanding of SARS-CoV-2-host interaction is therefore critical to identify cellular factors that play a role in SARS-CoV-2 infection, and develop novel antiviral strategies to limit virus spreading.

Current information on SARS-COV-2 interactions with host cells is mainly inferred from studies on related coronaviruses, with a rapidly increasing number of new studies that are confirming these findings in SARS-COV-2 or underlining differences (Hartenian et al., 2020) .

SARS-COV-2 enters the cells through the binding of the Spike protein to the receptor ACE2 by either direct membrane fusion or endocytosis (Hoffmann et al., 2020) . In the former case, after binding ACE2, the membrane fusion activity of the Spike protein is triggered by a proteolytic cleavage mediated by the transmembrane serine protease 2 (TMPRSS2). In the latter case, once endocytosed, Spike is activated by cathepsins in a pH-dependent manner, which can be inhibited by lysosomotropic agents (Pislar et al., 2020; Sauvat et al., 2020) . After uncoating, the polyprotein 1a/1b is translated from the genomic RNA and processed into 11 non-structural proteins (NSPs), including the RNA-dependent RNA polymerase (NSP12) and a small number of cofactors for viral replication. These proteins mediate the synthesis of the negative strand RNA that, in turn, serves as a template for generation of positive strand progeny genomes (Fung and Liu, 2019; Hartenian et al., 2020; Ortiz-Prado et al., 2020) . The replication complex localizes to modified host membranes including double-membrane vesicles (DMVs) that are derived from the endoplasmic reticulum (Snijder et al., 2020) . Viral and host RNA-binding proteins have been identified in association with the viral genome and contribute to driving translation and replication. For instance, phosphorylation of the SARS-CoV Nucleoprotein mediated by the host protein kinase GSK3 recruits the DEAD-box helicase 1 (DDX1) to the viral genome to facilitate template read-through during viral replication (Wu et al., 2014) . The RNA-binding protein hnRNPA1 also tightly binds to SARS-CoV Nucleoprotein and regulates viral RNA synthesis (Luo et al., 2005) .

Subgenomic RNAs are also obtained during replication by discontinuous transcription (Kim et al., 2020) , which encode for the structural proteins Spike, Membrane, Envelope, and J o u r n a l P r e -p r o o f Nucleoprotein, required for viral particle assembly and release (Siu et al., 2008) , as well as accessory proteins (ORFs 3-9), not required for viral replication but responsible for the modulation of host antiviral response (Liu et al., 2014) . Particle assembly occurs in the ER-Golgi intermediate compartment (ERGIC) and trafficked via the secretory pathway to be released by exocytosis (Stertz et al., 2007) .

Interestingly, sequence alignment of different Coronaviruses shows that the structural proteins are less conserved than the non-structural proteins, suggesting that the former are more diverse in need of adaptation to new hosts, which prioritize their study to understand the unique feature of SARS-CoV-2 (Cui et al., 2019) .

A proteomic characterization on SARS-CoV-2 interactome upon ectopic expression of individual viral proteins has been recently reported (Gordon et al., 2020) , providing crucial information on host processes that are targeted by SARS-CoV-2, most of which remain to be validated in infected cells to elucidate their functional role. To deepen the knowledge of the molecular mechanisms underlying SARS-CoV-2 infection, we have carried out a mass spectrometry analysis of host proteins interacting with SARS-CoV-2 Nucleoprotein in infected Vero E6 cells. q R T -P C R a n d v ir a l ti tr a ti o n V ira l R N A w a s e x tra c te d fro m V e ro E 6 a n d C a lu -3 c e lls u s in g T riz o l (L ife T e c h n o lo g ie s , 1 5 5 9 6 0 1 8 ), a c c o rd in g to th e m a n u fa c tu re r's in s tru c tio n s . E x tra c e llu la r R N A w a s p u rifie d a s d e s c rib e d (R e fo lo e t a l., 2 0 1 9 ).

S A R S -C o V -2 R N A w a s a m p lifie d b y q u a n tita tiv e R T -P C R (q R T -P C R ) in R o to r-G e n e Q R e a l-T im e c y c le r (Q ia g e n ) u s in g R e a lS ta r® S A R S -C o V -2 R T -P C R K it 1 .0 (A lto n a D ia g n o s tic Clarified supernatants were applied at serial 5-fold dilutions on Vero E6 cells seeded in 96well plates at 30,000 cells/well and cytopathic effects were evaluated after 5 days.

Immunoprecipitation and immunoblotting were performed as previously described ( was calculated using the JacoP plugin of ImageJ software, as previously described (Romagnoli et al., 2018) . A minimum of 50 cells per sample experimental condition were counted for triplicate samples per condition in each experiment. the Perseus software v.1.6.12 to select proteins that were reproducibly identified to be associated with the SARS-CoV-2 nucleoprotein, as previously described (Tyanova et al., 2016) . Analysis of biological processes associated to the identified interacting proteins was carried out with the STRING software (Szklarczyk et al., 2019) .

Statistical analysis of immunoblotting and PCR was performed using unpaired, two-tailed Student's t-test (Excel software). Values are shown as mean +/-standard deviation of three independent experiments. Confocal data analysis was performed using a non-parametric twotailed Mann-Whitney U-test (GraphPad Prism). Values are shown as mean +/-standard error of the mean of three independent experiments. P-values <0.05 were marked by *, p<0.01= **, p<0.001= ***. Densitometric analysis of immunoblots was performed using the Adobe Photoshop software. The control ratio was arbitrarily defined as 1.00. No exclusion criteria were applied to exclude samples from analysis. Samples were not randomized. Normal distribution for t-test analysis was assumed based on the appearance of the data, since n<5.

Statistical methods were not used to predetermine sample sizes and investigators were not blinded to group allocation or when assessing the outcome.

J o u r n a l P r e -p r o o f

Vero E6 cells were infected with SARS-CoV-2 at multiplicity of infection (MOI) 0.01, lysed after 24 hours and protein extracts were subjected to immunoprecipitation using an anti-Nucleoprotein antibody ( Figure 1A ). Purified proteins were tryptic digested and analysed by mass spectrometry. Results from two experiments performed in duplicate identified a list of 24 cellular proteins and 3 viral proteins that specifically interact with the Nucleoprotein ( Figure 1B and Tables S1 and S2). Similar to what reported for other Coronaviruses, Nucleoprotein was found in association with the structural proteins Membrane and Spike, and the non-structural proteins NSP3 and NSP4 (Table S1) 

First, we verified the interaction of Nucleoprotein with the stress granule component G3BP1 in SARS-CoV-2 infected cells by immunoprecipitation using an anti-Nucleoprotein antibody different from that used in the mass spectrometry analysis. Immunoblotting analysis of Nucleoprotein associated proteins confirmed its interaction with G3BP1 ( Figure 2A) . Then, we asked whether G3BP1 is a host factor required for SARS-CoV-2 replication using a RNA interference approach. Vero E6 cells were transfected with short interfering RNA duplexes J o u r n a l P r e -p r o o f (siRNA) specific for G3BP1, or non-targeting siRNA as negative control, and infected with SARS-CoV-2 at MOI 0.001. Twenty-four hours later, cells were harvested and intracellular viral RNA analysed by RT-qPCR. As shown in Figure 2B , SARS-COV-2 RNA levels are significantly reduced when G3BP1 expression was downregulated, suggesting that

Nucleoprotein targets G3BP1 to favour viral replication.

Since that Nucleoprotein was found to interact with several components of stress granules, we asked if SARS-CoV-2 infection impacts on the formation of these cytoplasmic bodies. To 

Next, we investigated if Nucleoprotein interacts with "druggable" host factors critical for SARS-CoV-2 replication. We decided to focus on the role of the RNA helicase DDX3X for two main reasons: a) a proviral role of DDX3X, associated to its ability to unfold viral RNA secondary structures (Kukhanova et al., 2020) , has been reported for numerous viruses,

including West Nile and HIV-1 (Brai et al., 2019; Brai et al., 2020) ; b) specific inhibitors of DDX3X with antiviral activity are currently available (Maga et al., 2011; Brai et al., 2020) .

First, we verified the interaction of Nucleoprotein with DDX3X in SARS-CoV-2 infected cells by immunoprecipitation using an anti-Nucleoprotein antibody different from that used in the mass spectrometry analysis. Immunoblotting analysis of Nucleoprotein associated proteins confirmed the binding with DDX3X ( Figure 3A ). DDX3X-Nucleoprotein interaction was also confirmed in reverse co-immunoprecipitation by using an anti-DDX3X antibody ( Figure 3B ).

Then, we assessed if DDX3X is recruited to the replication complex by analysing the colocalization with the SARS-CoV-2 genome by confocal microscopy using an anti-double strand RNA (dsRNA) antibody commonly used to detected positive strand RNA viruses (Weber et al., 2006) . As shown in Figure 3C and Figure S1A , DDX3X staining partially overlaps with the viral RNA, suggesting that DDX3X is recruited to the viral replication sites.

The specificity of dsRNA antibody in detecting the viral genome was verified by staining uninfected cells ( Figure S1B ).

Then, we asked whether DDX3X is a host factor required for SARS-CoV-2 replication using a RNA interference approach. Vero E6 cells were transfected with short interfering RNA duplexes (siRNA) specific for DDX3X, or non-targeting siRNA as negative control, and infected with SARS-CoV-2 at MOI 0.001. Twenty-four hours later, cells were harvested and intracellular viral RNA analysed by RT-qPCR. As shown in Figure 3D , SARS-COV-2 RNA levels are significantly reduced when DDX3X expression was downregulated, suggesting that Nucleoprotein recruits DDX3X to the replication complex for novel virus production.

Prompted by these results, we assessed if DDX3X is required for SARS-CoV-2 infection by using two specific inhibitors of DDX3X, the diazepine derivative RK-33 inhibitors on SARS-CoV-2 replication was confirmed when the infectivity of viral particles produced in cells treated with different concentrations of RK-33 or C-4B was measured by limiting dilution assay ( Figure 4E ).

Finally, we evaluated the ability of DDX3X inhibitors to affect SARS-CoV-2 replication in human cells. To this aim, the lung adenocarcinoma cell line Calu-3 was infected with SARS-CoV-2 at MOI 0.001 for 1 hour followed by incubation with the RK-33 or C-4B compounds at 3 different concentrations for 24 hours. No cytopathic effects were observed at any drug concentration (data not shown). The analysis of intracellular and extracellular viral RNA by RT-qPCR confirmed that both DDX3X inhibitors impairs SARS-CoV-2 replication in a dose dependent manner ( Figure 5A and B). The antiviral effect of DDX3X inhibitors was also confirmed when the infectivity of viral particles produced in cells treated with different concentrations of RK-33 or C-4B was measured by limiting dilution assay ( Figure 5C ).

Virus-host interaction represents an ongoing evolutionary arms race accomplished at molecular and cellular levels, whose in-depth characterization can unveil sensitive targets to stop infections (de Chassey et al., 2014) . Here, we used a mass spectrometry-based approach to study the interactome of SARS-CoV-2 Nucleoprotein in infected cells. We identified the interaction of Nucleoprotein with ribosomal proteins and a number of proteins involved in RNA metabolism, including factors regulating stress granule assembly. The interaction of Nucleoprotein with stress granule components was recently identified in a interactome study performed by Gordon and colleagues upon overexpression of single SARS-CoV-2 proteins (Gordon et al., 2020) . Here, using an infectious cell system, we confirmed that some of these interactions, e.g. G3BP1, occur in infected cells, and identified additional factors, e.g. DDX3X, playing a role in SARS-CoV-2 infection.

Stress granules are cytoplasmic aggregates of the translation pre-initiation complex 48S, which accumulate in response to inhibition of translation initiation induced by stress signals often resulting in eIF2α phosphorylation (Protter and Parker, 2016) . Stress granule formation is an integral part of antiviral response aimed at blocking viral gene expression (Tsai and Lloyd, 2014) . In addition, stress granules can function as novel signalling platforms and regulate antiviral response pathways (McCormick and Khaperskyy, 2017).

Interestingly, we found that Nucleoprotein interacts with the scaffold proteins of stress granules, such as G3BP1, G3BP2, IGF2BP2, IGF2BP3 and YBX1, but other components typical of this type of aggregate, such as eukaryotic initiation factors, were not detected, suggesting that Nucleoprotein does not associate with the entire assembled structure. Indeed, the analysis of the distribution of G3BP1 in infected cells showed that this protein is not present in dotted structures. Importantly, downregulation of G3BP1 expression results in a decrease of viral replication, suggesting that SARS-CoV-2 hijacks stress granule components for its life cycle. Absence of stress granules in infected cells was also confirmed when the distribution of eIF4G and the levels of eIF2α phosphorylation were analysed. Whether

Nucleoprotein interferes with stress granule formation through the direct interaction with scaffold proteins or by binding and modulating the activity of the eIF2α phosphatase PP1 remains to be determined. Conversely, we observed that stress granules and high levels of eIF2α phosphorylation are present in neighbouring non-infected cells. This result suggests that infected cells release signals able to induce stress granules in non-cell-autonomous J o u r n a l P r e -p r o o f manner, as described in other pathological conditions (Hu et al., 2010; Grabocka and Bar-Sagi, 2016 ).

Among Nucleoprotein interacting proteins involved in stress granule dynamics, we identified DDX3X as a "druggable" target required for SARS-CoV-2 replication. DDX3X belongs to the large DEAD-box family of ATP-dependent RNA helicases and plays a role in several aspects of RNA metabolism, such as transcription, splicing, mRNA export and initiation of translation (Ariumi, 2014) . Multiple lines of evidence point at a role of DDX3X in viral infection (Valiente-Echeverría et al., 2015) as either a cofactor of viral replication or a mediator of the innate immunity system. DDX3X regulates the replication of viruses belonging to different families, such as HCV, Dengue, West Nile, HIV-1, HBV, Vaccinia, Norovirus and influenza A virus, by interacting with both viral RNA and viral proteins (Valiente-Echeverría et al., 2015) . In particular, it is well characterized its role in HIV infection where, by unfolding viral RNA secondary structures, DDX3X enhances both nucleus-to-cytoplasm transport and translation of HIV genome (Stunnenberg et al., 2018) . In apparent contradiction with its proviral functions, DDX3X participates in antiviral signaling pathways by regulating the activity of TBK1, IKK  and MAVS (Soulat et al., 2008; Fullam and Schröder, 2013; Oshiumi et al., 2010) .

Here, we provided evidence that DDX3X interacts with Nucleoprotein, localizes with cytoplasmic viral RNA foci and is required for SARS-CoV-2 infection in Vero E6 and Calu-3 cells. Indeed, treatment of cells with two independent DDX3X inhibitors, RK-33 and C-4B, results in a significant inhibition of SARS-CoV-2 replication and viral production. Although we cannot rule out that DDX3X inhibitors may also target other DEAD RNA helicases, as reported for DDX1 at high micromolar concentration (Maga et al., 2011) , the results obtained both in the dose-response experiments and using small interfering RNAs corroborate a direct involvement of DDX3X in SARS-CoV-2 infection.

Based on these results, we hypothesize that, by preventing stress granule formation, Nucleoprotein can make DDX3X available to unfold SARS-CoV-2 RNA secondary structures and facilitate viral translation and replication. Notably, evidence of DDX3X association with SARS-CoV-2 RNA has been recently reported in a RNA interactome study (Schmidt et al., 2021) . In addition, Nucleoprotein could interact with DDX3X to inhibit its activity in antiviral response, a hypothesis that requires a different cell system to be tested since Vero E6 cells are defective for type I interferon induction.

Altogether, these results identify DDX3X as an attractive target for host-directed therapy to limit SARS-CoV-2 infection. Recently, novel DDX3X inhibitors aimed at inhibiting HIV infection have been developed showing optimal tolerability and biodistribution, which represent good candidates for clinical studies (Brai et al., 2020) . Moreover, the presence of DHX9 and DDX21 (Gordon et al., 2020) in the Nucleoprotein interactome suggests that multiple RNA helicases are potential candidates as host targets to halt SARS-CoV-2 replication.

J o u r n a l P r e -p r o o f 

Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection

DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins

DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection

Origin and evolution of pathogenic coronaviruses

Virushost interactomics: new insights and opportunities for antiviral drug discovery

Host Factors in Coronavirus Replication

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains

DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication

Human Coronavirus: Host-Pathogen Interaction

Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules

The molecular virology of Coronaviruses

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Stress granule formation mediates the inhibition of colonic Hsp70 translation by interferon-gamma and tumor necrosis factor-alpha

The Architecture of SARS-CoV-2 Transcriptome

DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs

Activation and evasion of type I interferon responses by SARS-CoV-2

Accessory proteins of SARS-CoV and other coronaviruses

The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1

Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation

Translation inhibition and stress granules in the antiviral immune response

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential

The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

Principles and Properties of Stress Granules

Negative Regulation of Mitochondrial Antiviral Signaling Protein-Mediated Antiviral Signaling by the Mitochondrial Protein LRPPRC During Hepatitis C Virus Infection

Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1beta-induced autophagy

Interplay between SARS-CoV-2 and the type I interferon response

On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2

The SARS-CoV-2 RNA-protein interactome in infected human cells

The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response

The intracellular sites of early replication and budding of SARScoronavirus

DDX3 in HIV-1 infection and sensing: A paradox

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Cytoplasmic RNA Granules and Viral Infection

The Perseus computational platform for comprehensive analysis of (prote)omics data

RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity

Doublestranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses

Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription

RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X

Anti-SARS-CoV SPIKE antibody was also used to detect SARS-CoV-2 positive cells. The graph in (H) reports means ± SEM of percentage of p-eIF2α positive cells among uninfected and infected cells from three independent experiments. *** = p < 0.001. NI: non-infected; N PROTEIN: Nucleoprotein

Figure 3. SARS-CoV-2 Nucleoprotein interacts with DDX3X

Immunopurified complexes were analyzed by immunoblotting using anti-SARS-CoV Nucleoprotein and anti-DDX3X antibodies. C) Vero E6 cells infected with SARS-CoV-2 at MOI 0.01 were fixed after 24 hours and analyzed for DDX3X and dsRNA localization by immunofluorescence using specific antibodies. Bottom panel shows colocalization trace profiles. Colocalization rate was measured by Mander's overlap coefficient (MOC) on 25 cells by using ImageJ software

D) Vero E6 cells were transfected with small interfering RNAs specific for DDX3X (siDDX3Xa and siDDX3Xb), or non-targeting siRNA (siCTR) as negative control, and infected with SARS-CoV-2 at MOI 0.001. Twenty-four hours later, cells were harvested and DDX3X and viral RNAs were analysed by RT-qPCR. The graphs report means ± SD of normalized values from three independent experiments

Inhibition of SARS-CoV-2 infection by RK-33 and C-4B in Vero E6 cells

B-D) Vero E6 cells were infected with SARS-CoV-2 at MOI 0.001 and, at the end of the adsorption period, were treated with RK-33 10 µM, C-4B 10 µM or left untreated, as indicated